The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Cohort profile: ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden)
Open accessAbstract
The ESPRESSO study constitutes a novel approach to examine the etiology and prognosis of gastrointestinal disease in which histopathology plays a prominent role. Between 2015 and 2017, all pathology departments (n=28) in Sweden were contacted and asked to procure histopathology record data from the gastrointestinal tract (pharynx to anus), liver, gallbladder, and pancreas. For each individual, local histopathology IT personnel retrieved data on personal identity number, date of histopathology, topography (where the biopsy is taken), morphology (biopsy appearance), and where available free text. In total, between 1965 and 2017, histopathology record data were available in 2.1 million unique individuals, but the number of data entries was 6.1 million because more than one biopsy was performed in many of the study participants. Index individuals with histopathology data were matched with up to five controls from the general population. We also identified all first-degree relatives (parents, children, full siblings), and the index individual's first spouse. The total study population consisted of 13.0 million individuals. Data from all the study participants have been linked to Swedish National Healthcare Registers allowing research not only on such aspects as fetal and perinatal conditions and the risk of future gastrointestinal disease but also on the risk of comorbidity and complications (including cancer and death). Furthermore, the ESPRESSO database allows researchers and practitioners to identify diagnoses and disease phenotypes not currently indexed in national registers (including disease precursors). The ESPRESSO database increases the sensitivity and specificity of already-recorded diseases in the national health registers. This paper is an overview of the ESPRESSO database.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055 · cited 2×
“From 2004 to 2007, the principal investigator (JFL) of the ESPRESSO database published several scientific papers on coeliac disease using relevant International Classification of Disease (ICD) codes in the Swedish Inpatient Register.(9) However, it soon became evident that using inpatient data for the identification o…”
MethodSelf-citationHusby, S., Koletzko, S., Korponay‐Szabó, I. R., Mearin, M. L., Phillips, A., Shamir, R., Troncone, R., Giersiepen, K., Branski, D., Catassi, C., et al. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31821a23d0 · Cited by 2,683
Bi-directionality of brain–gut interactions in patients with inflammatory bowel disease
Gracie, D. J., Guthrie, E. A., Hamlin, P. J., & Ford, A. C. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.027 · Cited by 408 · cited 5×
“Although coeliac disease has been linked to a lower risk of lung cancer48 (possibly because of lower rates of smoking among patients),49 these same patients are probably at increased risk of both liver cancer and IBD.50,51 IBD of C lin ic al E pi de m io lo gy d ow nl oa de d fr om h ttp s: //w w w .d ov ep re ss .c o…”
BackgroundInfluentialBrain–gut–microbiota axis — mood, metabolism and behaviour
Dinan, T. G., & Cryan, J. F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.200 · Cited by 361
Butwicka, A., Frisén, L., Almqvist, C., Zethelius, B., & Lichtenstein, P. (2015) · Diabetes Care · doi:10.2337/dc14-0262 · Cited by 210
Mollazadegan, K., Kugelberg, M., Montgomery, S. M., Sanders, D. S., Ludvigsson, J., & Ludvigsson, J. F. (2013) · Diabetes Care · doi:10.2337/dc12-0766 · Cited by 82
Self-citationPredictors and risks for death in a population-based study of persons with IBD in Manitoba
Bernstein, C. N., Nugent, Z., Targownik, L. E., Singh, H., & Lix, L. M. (2015) · Gut · doi:10.1136/gutjnl-2014-307983 · Cited by 72
Laszkowska, M., Roy, A., Lebwohl, B., Green, P. H. R., Sundelin, H. E. K., & Ludvigsson, J. F. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.05.019 · Cited by 24
Self-citation
Cited by
Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
Simon, T. G., Roelstraete, B., Khalili, H., Hagström, H., & Ludvigsson, J. F. (2021) · Gut · doi:10.1136/gutjnl-2020-322786 · Cited by 673
Self-citationSimon, T. G., Roelstraete, B., Hagström, H., Sundström, J., & Ludvigsson, J. F. (2022) · Gut · doi:10.1136/gutjnl-2021-325724 · Cited by 321
Self-citationEbrahimi, F., Hagström, H., Sun, J., Bergman, D., Shang, Y., Yang, W., Roelstraete, B., & Ludvigsson, J. F. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.08.018 · Cited by 65
Metadata
- Authors
- Ludvigsson, J. F., & Lashkariani, M.
- Venue
- Clinical Epidemiology
- Publisher
- Informa UK Limited
- Published
- 2019-01
- Volume
- Volume 11
- Pages
- 101-114
- ISSN
- 1179-1349 (ISSN-L)
- OpenAlex
- W2911001738
- Cited by
- 184
- References
- 9
- FWCI
- 19.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cohort profile: ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden). https://app.cochat.ai/papers/10.2147/clep.s191914
- The paper
- Ludvigsson, J. F., & Lashkariani, M. (2019). Cohort profile: ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden). Clinical Epidemiology. https://doi.org/10.2147/clep.s191914
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.